Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2007			2006			2007			2006
Net Sales:
Aerospace & Electronics	$	158,999		$	139,487		$	467,563		$	420,480
Engineered Materials		80,719			71,636			256,180			239,931
Merchandising Systems		98,462			73,384			296,389			179,566
Fluid Handling		290,826			252,278			834,983			744,109
Controls	$	35,087			30,919			98,093			91,151
Total Net Sales		664,093		$	567,704		$	1,953,208		$	1,675,237
Operating Profit (Loss):
Aerospace & Electronics	$	23,090		$	25,041		$	68,481		$	73,414
Engineered Materials		15,742			9,661			49,713			38,551
Merchandising Systems		9,755			8,887			31,298			17,101
Fluid Handling		37,477			29,188			102,014			84,596
Controls		3,129			2,559			8,331			7,353
Corporate		(11,660	)		(4,173	)		(42,108	)		(26,546	)
Asbestos Provision		(390,150	)		—			(390,150	)		—
Total Operating Profit (Loss)		(312,617	)		71,163			(172,421	)		194,469
Interest Income		1,535			552			3,837			2,164
Interest Expense		(6,845	)		(5,244	)		(20,614	)		(16,268	)
Miscellaneous- Net		849			1,461			3,593			7,143
Income (Loss) Before Income Taxes		(317,078	)		67,932			(185,605	)		187,508
Provision for Income Taxes		(120,128	)		21,889			(78,036	)		59,602
Net Income (Loss)	$	(196,950	)	$	46,043		$	(107,569	)	$	127,906
Share Data:
Net Income (Loss) per Diluted Share	$	(3.29	)	$	0.74		$	(1.79	)	$	2.06
Average Diluted Shares Outstanding		59,884			62,226			60,008			62,192
Average Basic Shares Outstanding		59,884			61,110			60,008			60,941
Supplemental Data:
Cost of Sales - Operations	$	445,603		$	378,054		$	1,321,560		$	1,125,978
Asbestos Provision		390,150			—			390,150			—
Selling, General & Administrative		140,957			118,487			413,919			354,790
Depreciation and Amortization		13,672			12,259			44,740			39,056
Stock Compensation Expense		3,797			3,169			11,173			11,288

CRANE CO.

Condensed Balance Sheets

(in thousands)

	September 30, 2007		December 31, 2006
ASSETS
Current Assets
Cash and Cash Equivalents	$	162,248	$	138,607
Accounts Receivable		390,315		330,146
Current Insurance Receivable - Asbestos		32,000		52,500
Inventories		343,079		313,259
Other Current Assets		61,297		45,897
Total Current Assets		988,939		880,409
Property, Plant and Equipment		295,520		289,555
Long-Term Insurance Receivable - Asbestos		319,249		170,400
Long-Term Deferred Tax Assets		299,703		171,164
Other Assets		235,309		214,220
Goodwill		776,577		704,736
Total Assets	$	2,915,297	$	2,430,484
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Notes Payable and Current Maturities of Long-Term Debt	$	25,032	$	9,505
Accounts Payable		193,934		161,270
Current Asbestos Liability		80,000		70,000
Accrued Liabilities		215,762		196,723
Income Taxes		13,104		24,428
Total Current Liabilities		527,832		461,926
Long-Term Debt		398,256		391,760
Deferred Tax Liability		93,235		89,595
Long-Term Asbestos Liability		975,000		459,567
Other Liabilities		114,820		109,033
Shareholders' Equity		806,154		918,603
Total Liabilities and Shareholders' Equity	$	2,915,297	$	2,430,484

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2007			2006			2007			2006
Operating Activities:
Net income	$	(196,950	)	$	46,044		$	(107,569	)	$	127,906
Asbestos provision, net		250,000			—			250,000			—
Income from joint venture		(1,253	)		(1,306	)		(3,798	)		(4,525	)
Loss/(Gain) on divestitures		975			(664	)		975			(8,931	)
Depreciation and amortization		13,672			12,259			44,740			39,056
Stock-based compensation expense		3,797			3,169			11,173			11,288
Deferred income taxes		5,777			6,460			(3,691	)		4,954
Cash (used for) provided by operating working capital		10,198			(1,469	)		(35,934	)		(35,617	)
Other		(2,758	)		(7,962	)		(16,889	)		(1,258	)
Subtotal		83,458			56,531			139,007			132,873
Asbestos related payments, net of insurance recoveries		(7,897	)		(20,877	)		7,311			(29,957	)
Total provided by operating activities		75,561			35,654			146,318			102,916
Investing Activities:
Capital expenditures		(11,581	)		(5,311	)		(33,412	)		(22,312	)
Proceeds from disposition of capital assets		374			463			11,610			3,317
Proceeds from divestitures		2,005			208			2,005			26,088
Payment for acquisition, net of cash acquired		(65,311	)		(85,669	)		(65,166	)		(234,734	)
Total used for investing activities		(74,513	)		(90,309	)		(84,963	)		(227,641	)
Financing Activities:
Dividends paid		(10,789	)		(9,173	)		(28,828	)		(24,465	)
Reacquisition of shares on the open market		—			(12,500	)		(50,001	)		(37,499	)
Stock options exercised - net of shares reacquired		2,958			1,963			10,102			20,606
Excess tax benefit from stock-based compensation		1,954			800			4,081			7,575
Issuance of Debt		—			71,700			—			71,700
Net increase / decrease in short-term debt		23,889			(79	)		15,192			(355	)
Total used for financing activities		18,012			52,711			(49,454	)		37,562
Effect of exchange rate on cash and cash equivalents		8,113			857			11,740			5,848
Increase (decrease) in cash and cash equivalents		27,173			(1,087	)		23,641			(81,315	)
Cash and cash equivalents at beginning of period		135,075			100,164			138,607			180,392
Cash and cash equivalents at end of period	$	162,248		$	99,077		$	162,248		$	99,077

CRANE CO.

Order Backlog

(in thousands)

	September 30, 2007		December 31, 2006		September 30, 2006
Aerospace & Electronics	$	398,725	$	396,799	$	372,601
Engineered Materials		14,466		13,198		13,162
Merchandising Systems		30,825		33,170		18,637
Fluid Handling		266,920		210,532		204,157
Controls		42,217		22,982		30,396
Total Backlog	$	753,153	$	676,681	$	638,953

CRANE CO.

Non-GAAP Financial Measures

(in thousands, except for per share amounts)

	Three Months Ended September 30,						Nine Months Ended September 30,						Percent Change Three and Nine Months Ended September 30,
	2007			2006			2007			2006			2007		2007
INCOME ITEMS:
Net Sales	$	664,093		$	567,704		$	1,953,208		$	1,675,237		17.0	%	16.6	%
Operating Profit (Loss)	$	(312,617	)	$	71,163		$	(172,421	)	$	194,469
Asbestos Provision - Pre-Tax (a)		390,150			—			390,150			—
Environmental Reimbursement - Pre-Tax (b)		—			(4,900	)		—			(4,900	)
Government Settlement - Pre-Tax (c)		—			—			7,600			—
Operating Profit before Asbestos Provision, Environmental Reimbursement and Government Settlement	$	77,533		$	66,263		$	225,329		$	189,569		17.0	%	18.9	%
Percentage of Sales		11.7	%		11.7	%		11.5	%		11.3	%
Net Income (Loss)	$	(196,950	)	$	46,043		$	(107,569	)	$	127,906
Per Share	$	(3.29	)	$	0.74		$	(1.79	)	$	2.06
Asbestos Provision - Net of Tax (a)		250,000			—			250,000			—
Per Share	$	4.18					$	4.16
Environmental Reimbursement - Net of Tax (b)		—			(3,185	)		—			(3,185	)
Per Share				$	(0.05	)				$	(0.05	)
Government Settlement - Net of Tax (c)		—			—			5,396			—
Per Share							$	0.09
Net Gain on Divestitures - Net of Tax (d)		—			—			—			(1,779	)
Per Share										$	(0.03	)
Net Income before Asbestos Provision, Environmental Reimbursement, Government Settlement and Gain on Divestitures	$	53,050		$	42,858			147,827		$	122,942		23.8	%	20.2	%
Per Share	$	0.89					$	2.46
Per Diluted Share	$	0.87		$	0.69		$	2.42		$	1.98		26.3	%	22.4	%
In the three months and nine months ended September 30, 2007, Average Shares Outstanding excluding the effect of diluted stock options were used to compute the per share amounts since both periods were in a loss position. Had net income been reported for these periods, Average Shares Outstanding would have included the effect of diluted stock options when computing per share amounts (see chart below).
Average Basic Shares Outstanding		59,884						60,008
Effect of Diluted Stock Options		1,164						1,087
Average Shares Outstanding including the effect of Stock Options		61,048						61,095
When considering the effect of dilutive stock options on shares outstanding, Net Income before Asbestos Provision, Environmental Reimbursement, Government Settlement and Gain on Divestitures is $0.87 per share and $2.42 per share for the three and nine months ended September 30, 2007, respectively.

(a) During the three months ended September 30, 2007, the Company recorded an Asbestos Provision.

(b) During the three months ended September 30, 2006, the Company recorded a reimbursement from the US Government for environmental clean-up costs.

(c) During the three months ended June 30, 2007, the Company recorded a settlement with the US Government.

(d) Net Gain on Divestitures, Net of Tax of $1.8 million consists of $4.5 million from the sales of Resistoflex Aerospace and Westad offset by $2.7 million from the sale of unused property resulting from prior plant consolidations and certain legal costs associated with previous divestitures.

CRANE CO.

Non-GAAP Financial Measures

(in thousands, except for per share amounts)

	September 30, 2007			December 31, 2006
BALANCE SHEET ITEMS
Notes Payable and Current Maturities of Long-Term Debt	$	25,032		$	9,505
Long-Term Debt		398,256			391,760
Total Debt		423,288			401,265
Less Cash and Cash Equivalents		(162,248	)		(138,607	)
Net Debt		261,040			262,658
Shareholders' Equity		806,154			918,603
Total Capitalization	$	1,067,194		$	1,181,261
Percentage of Net Debt to Total Capitalization		24.5	%		22.2	%
Shareholders' Equity	$	806,154		$	918,603
Asbestos Provision, Net of Tax		250,000			—
Shareholders' Equity before Asbestos Provision, Net of Tax		1,056,154			918,603
Net Debt		261,040			262,658
Total Capitalization before Asbestos Provision, Net of Tax	$	1,317,194		$	1,181,261
Percentage of Net Debt to Total Capitalization before Asbestos Provision, Net of Tax		19.8	%		22.2	%

	Three Months Ended September 30						Nine Months Ended September 30						Year Ended December 31,
	2007			2006			2007			2006			2007	2006
													(Estimated)
CASH FLOW ITEMS
Cash Provided from Operating Activities before Asbestos - Related Payments, Net of Insurance	$	83,458		$	56,531		$	139,007		$	132,873		$240,000 - 255,000	$	222,258
Asbestos Related Payments, Net of Insurance Recoveries		(7,897	)		(20,877	)		(24,189	)		(29,957	)	(51,500)		(40,563	)
Equitas Receipts		—			—			31,500			—		31,500		—
Cash Provided from Operating Activities		75,561			35,654			146,318			102,916		$220,000 - 235,000		181,695
Less: Capital Expenditures		(11,581	)		(5,311	)		(33,412	)		(22,312	)	(45,000)		(27,171	)
Free Cash Flow	$	63,980		$	30,343		$	112,906		$	80,604		$175,000 - 190,000	$	154,524

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

Free cash flow provides supplemental information to assist management and investors in analyzing the Company's ability to generate positive cash flow. Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, certain measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.

CRANE CO.

Non-GAAP Financial Measures

(in thousands, except for per share amounts)

	Twelve Months Ended December 31,
	2007 Guidance						2006
	Low			High
INCOME ITEMS:
Net Income (Loss)	$	(69,069	)	$	(64,869	)	$	165,887
Per Share	$	(1.15	)	$	(1.08	)	$	2.67
Third Quarter Asbestos Provision—Net of Tax (a)		250,000			250,000			—
Per Share	$	4.16		$	4.16
Fourth Quarter Tax Impact of Asbestos Provision (b)		3,583			3,583			—
Per Share	$	0.06		$	0.06
Environmental Reimbursement—Net of Tax (c)		—			—			(3,185	)
Per Share							$	(0.05	)
Government Settlement—Net of Tax (d)		5,396			5,396			—
Per Share	$	0.09		$	0.09
Net Gain on Divestitures—Net of Tax (e)		—			—			(1,779	)
Per Share							$	(0.03	)
Net Income before Asbestos Provision, Environmental Reimbursement, Government Settlement and Gain on Divestitures		189,910			194,110		$	160,923
Per Share	$	3.16		$	3.23
Per Diluted Share	$	3.11		$	3.18		$	2.59

In the forecasted twelve months ended December 31, 2007, Average Shares Outstanding excluding the dilutive effect of stock options were used to compute the per share amounts since the full year is forecasted to be in a loss position. Had net income been reported, Average Shares Outstanding would have included the dilutive effect of stock options when computing per share amounts (see chart below):

Average Basic Shares Outstanding	60,008
Effect of Dilutive Stock Options	1,087
Average Shares Outstanding including the effect of Stock Options	61,095

When considering the effect of dilutive stock options on shares outstanding, Net Income before Asbestos Provision, Environmental Reimbursement, Government Settlement and Gain on Divestitures is forecasted to be between $3.11 and $3.18 for the twelve months ended December 31, 2007.

(a) During the three months ended September 30, 2007, the Company recorded an Asbestos Provision.

(b) During the three months ended September 30, 2007, the Company recorded an Asbestos Provision which increased the Company’s annual effective tax rate. This amount represents the fourth quarter impact of that increase.

(c) During the three months ended September 30, 2006, the Company recorded a reimbursement from the US Government for environmental clean-up costs.

(d) During the three months ended June 30, 2007, the Company recorded a settlement with the US Government.

(e) Net Gain on Divestitures, Net of Tax of $1.8 million consists of $4.5 million from the sales of Resistoflex Aerospace and Westad offset by $2.7 million from the sale of unused property resulting from prior plant consolidations and certain legal costs.